A23V 2250/70
Vitamins
A23V2250/70 (Vitamins) appears on 73 US grants and 141 published applications in this corpus.
Search patents in A23V- Granted patents
- 73
- Published applications
- 141
- Assignees
- 56
- Inventors
- 232
- Latest grant
- 21 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 2 |
| 2011 | 0 | 3 |
| 2012 | 0 | 0 |
| 2013 | 1 | 3 |
| 2014 | 0 | 5 |
| 2015 | 2 | 5 |
| 2016 | 0 | 7 |
| 2017 | 3 | 3 |
| 2018 | 6 | 23 |
| 2019 | 5 | 40 |
| 2020 | 15 | 13 |
| 2021 | 16 | 10 |
| 2022 | 11 | 9 |
| 2023 | 3 | 7 |
| 2024 | 6 | 3 |
| 2025 | 3 | 5 |
| 2026 | 1 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- A23V 2250/704Vitamin bIndexing code32
- A23V 2250/708Vitamin cIndexing code27
- A23V 2250/71Vitamin dIndexing code20
- A23V 2250/712Vitamin eIndexing code20
- A23V 2250/702Vitamin aIndexing code9
- A23V 2250/72BiotinIndexing code6
- A23V 2250/714Vitamin kIndexing code4
- A23V 2250/716Vitamin mIndexing code0
All 9 subgroupsShow fewer
Recent patents
- Nutritional compositions and infant formula for promoting de novo myealination21 Jul 2026US 12,685,331 B2Societe des Produits Nestle S. A.
- Nutritional composition and infant formula for promoting de novo myelination2 Dec 2025US 12,484,608 B2Societe des Produits Nestle S. A.
- Methods and systems for reducing acrylamide concentration in heat-processed products21 Oct 2025US 12,446,601 B2Intercontinental Great Brands LLC
- Edible composition for alleviating visual fatigue14 Oct 2025US 12,440,532 B2Shanghai Lytone Biochemicals, LTD.
- Nutritional supplements22 Oct 2024US 12,121,050 B2Laminaria Group AB
- Extrudate comprising vitamin a23 Apr 2026US 2026/0107966 A1Dsm IP Assets B.V.
- Feed additive for reducing somatic cell count9 Apr 2026US 2026/0096579 A1Dsm IP Assets B.V.
- Multiphase active substance preparations1 Jan 2026US 2026/0000615 A1BASF SE
- Compositions and their use11 Sep 2025US 2025/0280863 A1Societe des Produits Nestle S. A.
- Deuterated caffeine and uses thereof7 Aug 2025US 2025/0248424 A1Lennham Pharmaceuticals, Inc.
Most cited
By later US patents
- Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the S-enantiomer and methods of use42US 10,245,243 B1Axcess Global Sciences, LLC · 2019
- Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the S-enantiomer and methods of use30US 10,596,128 B2Axcess Global Sciences, LLC · 2020
- Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the S-enantiomer and methods of use30US 10,596,130 B2Axcess Global Sciences, LLC · 2020
- R-beta-hydroxybutyrate, S-beta-hydroxybutyrate, and RS-beta-hydroxybutyrate mixed salt compositions30US 10,973,786 B2Axcess Global Sciences, LLC · 2021
- S-beta-hydroxybutyrate compounds and compositions enriched with S-enantiomer22US 11,185,518 B2Axcess Global Sciences, LLC · 2021